Serodus ASA Share Price

Stocks

03/17/03	Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.	PU
08/16/08	Serodus : Q&A delisting from Oslo Axess	PU
23/16/23	Serodus : Extraordinary general meeting held	PU
23/16/23	Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer	PU
02/16/02	Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016	PU

1 day

-5.56%

Manager	Title	Age	Since
Arnstein Gunnestad Endresen CEO	Chief Executive Officer	73	01/01/2023
Henrik Mordhorst DFI	Director of Finance/CFO	-	01/10/2019
Daniel Capion PRN	Corporate Officer/Principal	-	01/01/2021

Director	Title	Age	Since
Søren Elmann Ingerslev CHM	Chairman	-	01/01/2017
Terri Sebree BRD	Director/Board Member	68	01/04/2014
Viggo Gunnersen Harboe BRD	Director/Board Member	80	01/01/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SERODUS ASA	-5.56%	+7.94%	-	-	0
WUXI APPTEC CO., LTD.	-3.25%	+13.72%	+52.49%	+88.86%	6.29TCr
ARGENX SE	+2.44%	+3.65%	+34.11%	+74.67%	5.43TCr
BIONTECH SE	-1.07%	-1.79%	-18.07%	-14.36%	2.29TCr
INSMED INCORPORATED	+33.86%	+30.60%	+19.14%	+502.77%	2.87TCr
WUXI BIOLOGICS (CAYMAN) INC.	+10.83%	+18.38%	+52.76%	+4.58%	2.16TCr
GENMAB A/S	+8.63%	+9.82%	+41.10%	-19.68%	1.78TCr
PHARMAESSENTIA CORPORATION	-3.37%	+25.85%	+213.21%	+369.13%	1.65TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.20%	+11.51%	+34.94%	+681.88%	1.55TCr
EXELIXIS, INC.	-7.94%	-6.74%	+38.42%	+157.52%	1.31TCr
Average	+0.87%	+8.08%	+52.01%	+205.04%	2.82TCr
Weighted average by Cap.	+1.10%	+8.61%	+46.26%	+166.62%

Employees

Sector